These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 26422288)

  • 41. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
    El-Beshlawy A; Manz C; Naja M; Eltagui M; Tarabishi C; Youssry I; Sobh H; Hamdy M; Sharaf I; Mostafa A; Shaker O; Hoffbrand AV; Taher A
    Ann Hematol; 2008 Jul; 87(7):545-50. PubMed ID: 18351337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indices of iron homeostasis correlate with airway obstruction in an NHANES III cohort.
    Ghio AJ; Hilborn ED
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2075-2084. PubMed ID: 28790810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
    Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
    Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
    Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
    Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.
    Wahidiyat PA; Wijaya E; Soedjatmiko S; Timan IS; Berdoukas V; Yosia M
    Blood Cells Mol Dis; 2019 Jul; 77():67-71. PubMed ID: 30978615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of respiratory function tests in children and adolescents with type 1 diabetes].
    Pieniawska A; Horodnicka-Józwa A; Petriczko E; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2012; 18(1):15-20. PubMed ID: 22525686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum.
    Barteselli G; Dell'arti L; Finger RP; Charbel Issa P; Marcon A; Vezzola D; Mapelli C; Cassinerio E; Cappellini MD; Ratiglia R; Viola F
    Ophthalmology; 2014 Mar; 121(3):709-18. PubMed ID: 24314836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Liver and heart iron deposition status in patients with β thalassemia major: a multicenter study].
    Li C; Liu S; Wang Y; Wen F; Gao H; Chen G; Li C; Wu X; Fang J; Hao W; Liu R; Zhang X; Chu CW; Au W
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):90-3. PubMed ID: 24739717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N
    Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
    Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
    Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.
    Abdelrazik N
    Hematology; 2007 Dec; 12(6):577-85. PubMed ID: 17852442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of Deferasirox in Pediatric Thalassemia Patients: Experience from a Tertiary Care Hospital of Odisha.
    Panigrahi M; Swain TR; Jena RK; Panigrahi A; Debta N
    Indian J Pharmacol; 2020; 52(3):172-178. PubMed ID: 32873999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exercise performance in thalassemia major: correlation with cardiac iron burden.
    Sohn EY; Kato R; Noetzli LJ; Gera A; Coates T; Harmatz P; Keens TG; Wood JC
    Am J Hematol; 2013 Mar; 88(3):193-7. PubMed ID: 23339082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.
    Kattamis A; Kassou C; Berdousi H; Ladis V; Papassotiriou I; Kattamis C
    Haematologica; 2003 Dec; 88(12):1423-5. PubMed ID: 14687998
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of serum hepcidin in hereditary hemolytic anemias.
    El Beshlawy A; Alaraby I; Abdel Kader MS; Ahmed DH; Abdelrahman HE
    Hemoglobin; 2012; 36(6):555-70. PubMed ID: 23088733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.
    Mirlohi MS; Yaghooti H; Shirali S; Aminasnafi A; Olapour S
    Ann Hematol; 2018 Apr; 97(4):679-684. PubMed ID: 29318368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.